近距离放射治疗市场规模、份额和成长分析（按产品类型、技术、最终用户、应用和地区划分）—产业预测，2026-2033年

预计到 2024 年，近距离放射治疗市场规模将达到 8.7 亿美元，到 2025 年将达到 9.4 亿美元，到 2033 年将达到 17.8 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.3%。

由于癌症发病率上升、技术进步以及近距离放射治疗作为一种治疗选择日益接受，全球近距离放射治疗市场预计将迎来显着增长。这种创新的放射线治疗透过将放射性物质直接注入肿瘤部位，实现局部癌症的标靶治疗。近距离放射治疗使用多种放射性核种，包括铯-137、铱-192、金-198、碘-125和钯-103，以提高疗效。日益增长的癌症负担正在推动市场扩张，因为放射线治疗可以单独使用，也可以与其他治疗方法联合使用，用于根治性、安宁疗护和预防癌症。放射技术的最新进展实现了精确的剂量输送，改善了患者的治疗效果，并促进了医生在临床实践中采用该疗法。

近距离放射治疗市场驱动因素

患者对微创治疗方法日益增长的偏好，大大推动了近距离放射治疗市场的成长。由于其诸多优势，例如术后併发症更少、住院时间更短、康復更快，越来越多的患者选择此类治疗方法。近距离放射治疗通常在门诊进行，完美契合了患者对微创治疗的需求。随着越来越多的患者寻求兼顾舒适性和便利性的有效治疗方案，对近距离放射治疗的需求将持续增长，进一步推动市场发展，并有助于提升肿瘤治疗领域的患者照护体验。

近距离放射治疗市场限制因素

近距离放射治疗的实施受到许多因素的限制，例如需要专门的设备和基础设施来有效制定治疗计划、进行放射治疗以及确保患者安全。购买和安装这些设备需要大量的初期投入，这对医疗机构，尤其是资源匮乏地区的医疗机构而言，构成了一道难以克服的障碍。因此，儘管近距离放射治疗具有改善患者照护的潜在益处，许多医疗机构仍可能对投资该疗法犹豫不决。这种经济上的限制可能会限制近距离放射治疗作为一种治疗选择的发展和广泛应用，进而影响其在医疗机构中的普及程度。

近距离放射治疗市场趋势

近距离放射治疗市场正呈现出显着的器官保留治疗趋势，这主要得益于人们对以患者生活品质为优先的标靶癌症治疗需求的不断增长。近距离放射治疗对前列腺癌、乳癌和子宫颈癌等癌症尤其有效，它能够精准地输送辐射，同时显着减少对周围健康组织的损伤。这种标靶治疗不仅能够保护器官功能，也符合微创手术的整体发展趋势。随着医疗服务提供者和患者对这些优势的认识不断加深，预计近距离放射治疗的应用将会进一步扩大，从而巩固其作为肿瘤治疗方法首选方案的地位。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球近距离放射治疗市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• 种子
• 施用器/后荷机
• 电子束近距离放射治疗

全球近距离放射治疗市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 高剂量率（HDR）
• 低剂量率（LDR）

全球近距离放射治疗市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 专科诊所
• 其他的

全球近距离放射治疗市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

• 妇科癌症
• 摄护腺癌
• 乳癌
• 其他的

全球近距离放射治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Elekta（Sweden）
• Becton, Dickinson and Company（USA）
• Eckert & Ziegler（Germany）
• Theragenics（USA）
• iCAD（USA）
• CIVCO Medical Solutions（USA）
• Isoray Medical（USA）
• Best Medical International（USA）
• AngioDynamics（USA）
• Carl Zeiss Meditec（Germany）
• Nordion（Canada）
• Oncura（UK）
• Sensus Healthcare（USA）
• IBA（Belgium）
• RaySearch Laboratories（Sweden）
• ViewRay（USA）

结论与建议

Brachytherapy Market size was valued at USD 0.87 Billion in 2024 and is poised to grow from USD 0.94 Billion in 2025 to USD 1.78 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global brachytherapy market is poised for significant growth, fueled by the rising incidence of cancer, technological advancements, and the increasing acceptance of brachytherapy as a treatment option. This innovative radiation therapy involves the insertion of radioactive materials directly into the tumor site, allowing for targeted treatment of localized cancers. Brachytherapy utilizes various radionuclides, including Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103, enhancing its effectiveness. The escalating cancer burden serves as a catalyst for market expansion, as radiation therapy can be applied for curative, palliative, or prophylactic purposes, either alone or in conjunction with other treatments. The latest advancements in radiation techniques enable precise dose delivery, improving patient outcomes and driving physician adoption in clinical practice.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Market Segments Analysis

Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer,breast cancerand Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Market

The growing preference among patients for minimally invasive treatment options significantly influences the expansion of the brachytherapy market. Due to their association with fewer post-operative complications, shorter hospital stays, and quicker recovery periods, patients are increasingly opting for these procedures. Brachytherapy, which is often performed on an outpatient basis, aligns perfectly with this desire for less invasive options. As more individuals seek effective treatments that prioritize comfort and convenience, the demand for brachytherapy continues to rise, further driving market growth and enhancing patient care experiences in oncology.

Restraints in the Brachytherapy Market

The adoption of brachytherapy is hindered by the need for specialized equipment and infrastructure essential for effective treatment planning, radiation delivery, and ensuring patient safety. The considerable initial expenses associated with purchasing and installing this equipment present a significant barrier for healthcare facilities, particularly those in resource-limited areas. As a result, many institutions may hesitate to invest in brachytherapy solutions, which could otherwise enhance patient care. This financial constraint potentially limits the growth and accessibility of brachytherapy as a treatment option, thus impacting its overall adoption in various healthcare settings.

Market Trends of the Brachytherapy Market

The Brachytherapy market is witnessing a notable trend towards organ-preserving treatments, driven by the rising demand for targeted cancer therapies that prioritize patient quality of life. Particularly effective for cancers like prostate, breast, and cervical cancer, brachytherapy enables precise radiation delivery while significantly reducing harm to surrounding healthy tissues. This targeted approach not only maintains organ function but also aligns with the broader shift towards minimally invasive procedures. As healthcare providers and patients increasingly embrace these advantages, the adoption of brachytherapy is expected to grow, further solidifying its role as a preferred treatment modality in oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Brachytherapy Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Seeds
• Applicators and Afterloaders
• Electronic Brachytherapy

Global Brachytherapy Market Size by Technique & CAGR (2026-2033)

• Market Overview
• High Dose Rate (HDR)
• Low Dose Rate (LDR)

Global Brachytherapy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brachytherapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Others

Global Brachytherapy Market Size & CAGR (2026-2033)

• North America (Product Type, Technique, End User, Application)
  • US
  • Canada
• Europe (Product Type, Technique, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isoray Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nordion (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oncura (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations